170519 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving non-enzymic blood coagulation factors Fibrin; Fibrinogen
System for Determining a Functional Fibrinogen Concentration
#2NOVEL DIAGNOSTIC METHOD FOR DETECTION OF MYASTHENIA GRAVIS
#3THROMBIN AND FIBRINOGEN AS TARGETS FOR ATOPIC DERMATITIS DIAGNOSIS AND TREATMENT
#4USE OF GAMMA PRIME FIBRINOGEN AS A BIOMARKER IN THE ASSESSMENT OF COVID-19 INFECTIONS AND PROGNOSIS OF SEVERE DISEASE
#5MONITORING INFLAMMATION STATUS
#6Device and Methods
#7Methods of Diagnosing and Managing Bleeding Disorders
#8HEMOSTATIC ENZYME AND CARBOXYMETHYL CHITOSAN-CONTAINING COMPOSITION FOR BLOOD COAGULATION TEST, AND USE THEREOF
#9REPORTER LABELED ANNULAR CLOT SYSTEM FOR DIAGNOSIS AND RESEARCH
#10METHOD FOR SEPARATING TARGET MOLECULES OR PARTICLES FROM FIBRINOGEN-CONTAINING SAMPLES INCLUDING BLOOD COMPONENTS
#11METHOD FOR DETERMINING FIBRINOGEN
#12URINARY TRACT INFECTION DIAGNOSTIC
#13MONOCLONAL ANTIBODY AGAINST D-DIMER AND DIAGNOSIS AGENT FOR DETECTING D-DIMER, CROSSLINKED FIBRIN AND ITS DERIVATIVES CONTAINING D-DIMER BY USING THE ANTIBODY
#14METHODS OF ASSESSING RISK OF AND TREATING PREECLAMPSIA AND SUBTYPES THEREOF
#15DEVICE FOR DETECTING BLOOD COAGULATION CHARACTERISTICS AND APPLICATION OF DEVICE
#16METHODS AND SYSTEMS FOR DETECTION OF FIBRIN FORMATION OR REMOVAL AT THE NANO-SCALE
#17METHOD FOR FIBRINOGEN MEASUREMENT
#18D-DIMER-SPECIFIC APTAMERS AND METHODS OF USE IN DIAGNOSTICS, THERAPEUTIC AND THERANOSTIC PURPOSES
#19BLOOD COAGULATION TIME MEASUREMENT METHOD
#20METHODS OF DIAGNOSING MALIGNANT DISEASES
#21SYSTEMS AND METHODS FOR MONITORING PLATELET ACTIVATION
#22OPTIMIZED FRAGMENTATION FOR QUANTITATIVE ANALYSIS OF FUCOSYLATED N-GLYCOPROTEINS BY LC-MS-MRM
#23DETECTION DEVICE AND DETECTION METHOD OF DOT IMMUNOBLOTTING DETECTION
#24METHOD AND DEVICE FOR MEASURING THE FIBRINOGEN CONCENTRATION IN BLOOD SAMPLES
#25LOW-VOLUME COAGULATION ASSAY
#26Hemostatic Enzyme and Carboxymethyl Chitosan-Containing Composition for Blood Coagulation Test, and Use Thereof
#27Diagnostic for Discriminating Benign Mass From Ovarian Cancer and Application Thereof
#28Blood state analysis apparatus, blood state analysis system, blood state analysis method, and program
#29DEVICE, SYSTEM AND METHOD FOR DETERMINING A FIBRINOGEN LEVEL IN A BLOOD SAMPLE
#30Biomarkers of vascular disease
#31ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS
#32Device and methods
#33System and Method for Disease Surveillance and Disease Severity Monitoring for COVID-19
#34Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#35DEVICE AND METHODS
#36METHOD FOR SEPARATING TARGET MOLECULES OR PARTICLES FROM FIBRINOGEN-CONTAINING SAMPLES INCLUDING BLOOD COMPONENTS
#37USE OF QUINALDINE RED AND DERIVATIVES THEREOF IN PREPARATION OF KIT FOR DETECTING AMYLOID FIBRILS
#38FIBRINOGEN TEST
#39URINARY TRACT INFECTION DIAGNOSTIC
#40DETECTION OF HIGH RISK ARTERIAL THROMBOEMBOLIC DISEASES BY MARKERS OF COAGULATION AND HEMOSTATIC ACTIVATION
#41METHOD FOR PROVIDING DIAGNOSTIC INFORMATION FOR BILIARY TRACT CANCER AND APPARATUS FOR DIAGNOSING BILIARY TRACT CANCER
#42Compositions and methods for in vitro assays of fibrin activity
#43ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS
#44Methods for assessing treatment with a gastrointestinal implant
#45Fibrinogen-like protein 2 (FGL2) monoclonal antibodies and their use in cancer detection and treatment
#46Methods of diagnosing malignant diseases
#47Method of diluting a metred quantity of a test fluid for analysis
#48Method for identifying modulators of notch signaling
#49Blood coagulation system analysis system, blood coagulation system analysis method, and blood coagulation system analysis program
#50BLOOD STATE ANALYSIS APPARATUS, BLOOD STATE ANALYSIS SYSTEM, BLOOD STATE ANALYSIS METHOD, AND PROGRAM
#51Methods and assays for factor VIII activity
#52Method for measuring the plasma concentration of an analyte directly on a whole blood sample
#53TROPONIN I AND SOLUBLE UROKINASE RECEPTOR DETECTION FOR DETERMINING THE RISK OF CARDIOVASCULAR DISEASE
#54Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody
#55Anti-carbamylated protein antibodies and the risk for arthritis
#56Biomarkers of vascular disease
#57Method for analyzing blood specimen, and analyzer
#58Blood analyzing method for D dimer (DD) content
#59Method for determining the fibrinogen concentration in a biological sample
#60Device, system and method for determining a fibrinogen level in a blood sample
#61METHOD FOR SEPARATING TARGET MOLECULES OR PARTICLES FROM FIBRINOGEN-CONTAINING SAMPLES INCLUDING BLOOD COMPONENTS
#62ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS
#63Method for preparing a surface with a controlled coverage of nanograde particles
#64Anti-carbamylated protein antibodies and the risk for arthritis
#65METHOD FOR DETERMINING THE STRUCTURAL PROFILE OF A FIBRIN CLOT REFLECTING THE STABILITY THEREOF, IN ORDER TO PREDICT THE RISK OF BLEEDING, THROMBOSIS OR RETHROMBOSIS
#66Blood sample analyzing method, blood sample analyzer, and system
#67LOW-VOLUME COAGULATION ASSAY
#68Atypical hemolytic uremic syndrome (aHUS) biomarker proteins
#69Compositions and methods for in vitro assays of fibrin activity
#70Methods and assays for factor VIII activity
#71Method for identifying modulators of notch signaling
#72Simultaneous monitoring of fibrinogen and haematocrit in whole blood
#73Reagent for assaying D-dimer and kit of reagent for assaying D-dimer
#74PROTECTION OF TCR SIGNALING CHAINS IN CANCER PATIENTS AND ENHANCEMENT OF CAR-T CELL THERAPY
#75Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#76Test fluid collection system
#77DIAGNOSTIC ASSAY TO PREDICT CARDIOVASCULAR RISK
#78Method for measuring the plasma concentration of an analyte directly on a whole blood sample
#79Antibody against insoluble fibrin
#80Methods for monitoring tight clot formation
#81Low-volume coagulation assay
#82Monoclonal antibody against D-dimer and methods of use therefor
#83Method and system for estimating the quantity of an analyte contained in a liquid
#84Blood biomarkers for necrotizing enterocolitis
#85BIOMARKERS AND TEST PANELS USEFUL IN SYSTEMIC INFLAMMATORY CONDITIONS
#86DIAGNOSTIC ASSAY TO PREDICT CARDIOVASCULAR RISK
#87Method for separating target molecules or particles from fibrinogen-containing samples including blood components
#88Anti-FDP monoclonal antibody, FDP measurement reagent and reagent kit using same, and FDP measurement method
#89Reagent and reagent kit for measurement of FDP, and measurement method
#90HIGHLY SENSITIVE METHOD FOR ASSAYING TROPONIN I
#91Methods for measuring high molecular weight complexes of fibrinogen with fibronectin and fibulin-1
#92CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS CLUMPING FACTOR A IN COMPLEX WITH FIBRINOGEN DERIVED PEPTIDE AND USES THEREOF
#93METHODS FOR ASSESSING THE RISK OF CARDIOVASCULAR DISEASE
#94Monoclonal antibodies and method of immunological analysis of D-dimer
#955.9 kDa peptide immunoassay method
#96APPARATUS FOR PERFORMING HAEMOSTASIS TESTS
#97COMBINATION METHODS OF DIAGNOSING CANCER IN A PATIENT
#98METHODS AND USES FOR TREATING HEPATIC ISCHEMIA AND REPERFUSION INJURY
#99COLORIMETRIC SENSORS CONSTRUCTED OF DIACETYLENE MATERIALS
#100COMPOSITIONS FOR THE TREATMENT OF HCV AND HBV
#101METHOD FOR THE PREOPERATIVE DETERMINATION OF THE INTRAOPERATIVE RISK OF BLEEDING OF A PATIENT
#102Reagent for assaying D-dimer and kit of reagent for assaying D-dimer
#103METHODS FOR DETECTING AN ANALYTE
#104D-dimer, troponin, and NT-proBNP for pulmonary embolism
#105Microfluidic structure for detecting biomolecule and microfluidic device comprising the same
#106Carbamylated proteins and risk of cardiovascular disease
#107Protein Biomarkers for Alzheimer's Disease Detection
#108Fibrinogen immune complexes to diagnose and guide therapy in rheumatoid arthritis
#109Fibrinogen alpha and hemoglobin polypeptides as cancer markers
#110Crystal structure of clumping factor A in complex with fibrinogen derived peptide and uses thereof
#111Integrated apparatus and method to detect inflammatory states present in a sample of whole blood
#112Mass spectrometric determination of blood enzyme activity
#113Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody
#114Marker proteins for diagnosing liver disease and method of diagnosing liver disease using the same
#115Method for diagnosing diseases using a protein or degradation product based on half-life
#116METHOD FOR ASSESSING THE FIBRINOGEN CONTRIBUTION IN COAGULATION
#117Immunological assay for plasmin-digested products of stabilized fibrin
#118Materials and methods for the detection of nitrated fibrinogen
#119Labeling enzyme
#120Stable D-dimer liquid preparation
#121Colorimetric Sensor Constructed Of Diacetylene Materials
#122POLYCLONAL ANTIBODIES AGAINST FIBRINOGEN DEGRADATION PRODUCTS AND ASSOCIATED METHODS OF PRODUCTION AND USE
#123Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody
#124Endometriosis markers
#125Method for identifying an anti- streptococcal agent and its use for treating streptococcal infections
#126Serum biomarkers in ischaemic heart disease
#127Ectopic pregnancy markers
#128Colorimetric sensors constructed of diacetylene materials
#129Marker proteins for diagnosing liver disease and method of diagnosing liver disease using the same
#130Nitrated fibrinogen as a marker for coronary artery disease and rapid blood clot formation
#132Reagent for measuring clotting time and method for measuring clotting time